Verdezyne
Verdezyne Launches New Corrosion Inhibitor
15/02/17
CARLSBAD, Calif. and PORT WASHINGTON, N.Y. Verdezyne Inc., a synthetic biology company producing biobased chemicals, and Aceto Corporation (ACET), a leader in the marketing, sales and distribution of specialty chemicals in the U.S., announce the introduction of FerroShield HC, a nitrate-free dibasic acid mixture with exceptional ferrous corrosion inhibition properties.
Read More...
Read More...
Verdezyne Wins Bloomberg's New Energy Pioneer Award
07/04/16
Picked as One of 10 Game-Changing Companies from Around the World in Recognition of Innovation, Scalability and Momentum
CARLSBAD, Calif. — April 4, 2016 —Verdezyne, Inc., a synthetic biology company producing biobased chemicals, has been named a winner of the Bloomberg New Energy Pioneer Award 2016.
Read More...
CARLSBAD, Calif. — April 4, 2016 —Verdezyne, Inc., a synthetic biology company producing biobased chemicals, has been named a winner of the Bloomberg New Energy Pioneer Award 2016.
Read More...
Verdezyne Formalizes $48 million financing at ceremony attended by President Obama
28/04/14
CARLSBAD, Calif. & KUALA LUMPUR, Malaysia, April 28, 2014 - Verdezyne, Inc., a privately held industrial biotechnology company focused on producing renewable chemicals, has negotiated key terms for an investment of $48 million led by Malaysian multinational conglomerate, Sime Darby Berhad. The initiative was launched in a ceremony on Monday, April 28, at the Ritz-Carlton in Kuala Lumpur, Malaysia, attended by United States President Barack Obama, Malaysian Prime Minister Dato' Sri Najib Razak, Verdezyne President and CEO E. William Radany, Ph.D., and Sime Darby Berhad President and Group Chief Executive, Tan Sri Dato’ Seri Mohd Bakke Salleh. Read More...
VERDEZYNE’S XYLOSE ISOMERASE TECHNOLOGY ACQUIRED BY DUPONT INDUSTRIAL BIOSCIENCES
07/12/12
Carlsbad, Calif. December 17, 2012 Verdezyne, Inc., a privately held industrial biotechnology company focused
on producing renewable chemicals, announced the sale of its proprietary xylose isomerase technology, enabling the metabolism of 5 carbon sugars, to DuPont Industrial Biosciences, a world leader in science and innovation.
Read More...
on producing renewable chemicals, announced the sale of its proprietary xylose isomerase technology, enabling the metabolism of 5 carbon sugars, to DuPont Industrial Biosciences, a world leader in science and innovation.
Read More...
Verdezyne Opens Pilot Plant to Produce Bio-Based Adipic Acid
30/11/11
Carlsbad, Calif. – November 30, 2011 – Verdezyne, Inc. (“Verdezyne”), a privately held industrial biotechnology company focused on producing renewable chemicals and fuels from non-petroleum sources has opened its first pilot plant to produce adipic acid, a key component of nylon 6,6. The plant demonstrates proprietary method for producing adipic acid at lower costs than petroleum-based alternatives. Read More...
Verdezyne's Chief Scientific Officer to receive Charles D. Scott award
01/05/11
Verdezyne, Inc., an industrial biotechnology company developing cost-effective processes fro the production of renewable fuels and chemicals, announced today that Dr. STephen Pictaggio, Chief Scientific Officer, will be presented with the Charles D. Scott Award on May 5, 2011 at the 33’rd Symposium of Biotechnology for Fuels and Chemicals in Seattle, the premier meeting in its field.
Read More...
Read More...
Verdezyne and Lallemand Ethanol Technology Announce Partnership
07/04/10
CARLSBAD, CA. and MILWAUKEE, WI. — April 7, 2010 – Verdezyne, Inc., an industrial biotechnology company, and Lallemand Ethanol Technology, a global provider of yeast to the fuel ethanol industry, today announced they have signed an agreement to develop and commercialize a genetically enhanced high-yield ethanol producing yeast.
Verdezyne will use its suite of metabolic engineering tools to rapidly introduce a proprietary pathway into an industrial yeast strain provided by Lallemand. The enhanced yeast will produce more ethanol per unit of glucose compared with currently available strains. Lallemand will be responsible for process development, manufacturing and worldwide commercialization of the novel yeast. Under the terms of the agreement, Verdezyne will receive patent license fees and royalty payments.
Verdezyne will use its suite of metabolic engineering tools to rapidly introduce a proprietary pathway into an industrial yeast strain provided by Lallemand. The enhanced yeast will produce more ethanol per unit of glucose compared with currently available strains. Lallemand will be responsible for process development, manufacturing and worldwide commercialization of the novel yeast. Under the terms of the agreement, Verdezyne will receive patent license fees and royalty payments.